ArticlePloS one2026

Soluble ST2 as a biomarker for predicting severe adverse events among pediatric patients with Mycoplasma pneumoniae pneumonia.

Fangying Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.